Characterized as a metabolic syndrome with multiple consequences for the lives of patients, diabetes mellitus is also classified as a chronic non-communicable disease of great scope in the world. It is a complex disease, with different points of view, including the relation between inflammatory process, obesity and insulin resistance due to the performance of the various immunoinflammatory mediators - called adipokines - on glycemic homeostasis. Recent studies have precisely addressed this aspect for the development of drugs that assist in the protection of pancreatic ß cells from the damages arising from oxidative stress and inflammatory process, in order to control the hyperglycemic picture, which is characteristic of diabetes mellitus.
CITATION STYLE
Gomes, B. F., & Accardo, C. de M. (2019, February 25). Immunoinflammatory mediators in the pathogenesis of diabetes mellitus. Einstein (Sao Paulo, Brazil). NLM (Medline). https://doi.org/10.31744/einstein_journal/2019RB4596
Mendeley helps you to discover research relevant for your work.